News
Genetic Analysis Joins Microbiome Therapeutics Innovation Group
The Microbiome Therapeutics Innovation Group (MTIG) announced today the addition of Norwegian molecular diagnostic company Genetic Analysis AS to its…
Interview with GA’s PhD student
Pranvera Hiseni works on an industrial PhD scheme in collaboration with GA and NMBU. In addition to working on improving current detection…
Genetic Analysis AS announces that a patent was granted in the US, from family WO2016120494A
“METHOD AND PRODUCT FOR PREVENTING FALSE POSITIVES IN METHODS EMPLOYING DDNTP’S”. In March 2019, GA signed a license agreement with…
Genetic Analysis AS announces that a patent was granted in India, from family WO2012080754A2
“OLIGONUCLEOTIDE PROBE SET AND METHODS OF MICROBIOTA PROFILING”. We are very pleased to inform that our patent “Oligonucleotide probe set…
The Importance of Scale in Evaluating the Gut Microbiome
In a recent study performed by prof. Peter Malfertheiner the aim was to analyze the levels of two different types…
Launch of the GA-map COVID-19 Fecal Test.
Genetic Analysis (GA) launched in August a CE-marked IVD test to detect SARS-CoV-2 in the gut. SARS-CoV-2 has been detected…
The GA-map® Dysbiosis Test was used for microbiota determinations of the effects of high intake of cod or salmon
In a study published on the 27 October 2020 from Haukeland University Hospital the effects of high intake of cod…
Research on gastrointestinal infection on COVID-19
Research on gastrointestinal infection on COVID-19. (January 2021) The National Competence Service for Functional Gastrointestinal Diseases (NKFM) hastogether with Genetic…
Genetic Analysis AS announces that two patents were granted in Russia and EU, from family WO2016156251A1
“METHOD FOR DETERMINING GASTROINTESTINAL TRACT DYSBIOSIS”. New IP secured – Important patents enhancing the use of GA-map® granted in EU…
Successful share issue and change in the management team
Successful share issue Genetic Analysis AS announces the successful private placement of NOK 34.3 million. The issue was oversubscribed and completed in two…